IFT International Food Nanoscience Conference
Michael Adams received his A.B. in chemistry from St. Michael's College (Vermont) and his M.S. and Ph.D. in chemistry and pharmacology from Cornell University (Ithaca, New York). He was a Damon Runyon Research Foundation Fellow for two years at Columbia University (New York City). During that period, he studied the chemistry of vision and synthesis of natural products, as well as developing micro-scale analytical techniques. Following that fellowship, he joined the faculty of the Monell Chemical Senses Center in Philadelphia. Over an eight year period at Monell, Dr. Adams studied the chemistry of chemoreception in terrestrial and aquatic organisms. Dr. Adams then joined the U. S. Food and Drug Administration where he has worked for over 20 years and currently is Deputy Director of the Office of Food Additive Safety in the Center for Food Safety and Applied Nutrition.
Gail Barnes, Ph.D., M.B.L.
Dr. Gail Barnes is a technical expert and strategic partner to processors, manufacturers and packaging suppliers, providing insights on sustainability, product innovation, consumer insights, food safety and regulatory processes and procedures. She has previously served as vice president of technology and packaging for the Innovation Center for U.S. Dairy and Dairy Management Inc.™ In this position, she helped the dairy industry realize its sustainability goals by working as an expert resource internally and directly with processors, manufacturers and transporters. Barnes is a multilingual business development and strategic marketing professional with 18 years of international dairy industry experience.
Susann Bellmann is a Study Director in the field of gastrointestinal research at the Dutch Institute for Applied Scientific Research (TNO). Her educational background is Food and Nutritional Sciences and Pharmacology. Her current research and projects focus on the realistic simulation of gastrointestinal physiology in vitro and the investigation of the behaviour of nutrients and pharmaceutical compounds in the gastrointestinal tract. Next to her work as Study Director, she is a Co-Chair of the ILSI North America Nano- and Food Additives working group and leads the Dutch NanoNext project on 'Bioavailability of manufactured nanoparticles and In vitro assays to assess their passage across barriers biological barriers'.
Richard Canady, Ph.D. DABT (1997-2012)
Dr. Canady is Director of the Center for Risk Science Innovation and Application of the Washington DC-based ILSI Research Foundation which fosters collaborative research supporting risk management needs. He is a leading expert in regulatory risk assessment having led multidisciplinary teams of policy and technical experts in the resolution of a wide range of cutting edge health risk management issues over a 25 year public policy career. The topics covered by Dr. Canady included genomics, nanotechnology, biotechnology, obesity, contaminants in the environment and in foods, and medical product development.
Dr. Mitchell Cheeseman
Dr. Mitchell Cheeseman is a Managing Director in Steptoe's Washington office, where he is a member of the Regulatory & Industry Affairs Department. He has 20 years of experience as an official at the US Food and Drug Administration. Dr. Cheeseman left FDA in November 2011 after serving more than 5 years as a member of the leadership of the Center for Food Safety and Applied Nutrition. In this capacity, he led FDA's food ingredient and packaging programs including primary responsibility for the regulation of direct food additives and food contact substances, color additives, Generally Recognized as Safe (GRAS) food ingredients, and bioengineered food.
Shaun Clancy is Director of Product Regulatory Services for Evonik Corporation, the U.S. subsidiary of Evonik Industries of Germany. His focus at Evonik is on management of chemicals; communication of their hazards, exposures and risks; and how information on these topics are used to support product stewardship and compliance with pertinent laws.
Shaun is a chemist, did his undergraduate work at the University of Buffalo, State University of New York and performed his doctoral studies at Northwestern University. He chairs the American Chemistry Council's Health, Product & Science Policy Committee and represents Evonik on the ACC Nanotechnology Panel. He also represents Evonik on the Society of Chemical Manufacturers & Affiliates Chemical Risk Management Committee and the SOCMA Nanotechnology Small & Medium Enterprise Coalition. Dr. Clancy is active in the International Organization for Standardization's Technical Committee 229 (ISO TC229) on Nanotechnologies and is the convener of Task Group 2 on Consumer & Societal Dimensions of Nanotechnology. He participates in the Nanotechnology Committee of the Business & Industry Advisory Committee to the OECD and is the industry lead to Steering Group 5/6 of the Working Party on Manufactured Nanomaterials (WPMN) on Cooperation on Risk Assessment and Exposure Assessment. Shaun also serves on the external advisory boards of the Nanomaterial Registry and the University of Michigan Risk Science Center.
John DiLoreto is the founder of NanoReg, a professional services firm specializing in nanotechnology applications and the laws and regulations related to the development and use of nanoscale materials throughout the nanotechnology value chain. As Executive Director of the SOCMA Nanotechnology Coalition, Mr. DiLoreto leads an industry group focused on the advocacy needs of small and medium-sized producers and users of nanoscale materials. A key player in the nanotechnology safety debate, Mr. DiLoreto combines his BS degree in Chemical Engineering with decades of professional experience in the chemical industry and nanotechnology to provide services to nanotechnology firms and trade associations.
Timothy Duncan received his undergraduate degree in chemistry in 2000 from Haverford College, located just outside of Philadelphia. He attained his Ph.D. in physical/inorganic chemistry in 2006 from the University of Pennsylvania, where he synthesized and studied the photophysical properties of conjugated porphyrin arrays designed for medical diagnostic and optoelectronic applications under the advisorship of Professor Michael J. Therien. After graduation, he did a post-doc at the University of Pennsylvania in the lab of Professor So-Jung Park, where he built a single-molecule fluorescence imaging system in order to study the light emission properties of novel quantum-dot based bio-imaging agents and devised a new method to synthesize color-tunable conducting polymers.
After completing his Ph.D. in physics in Eindhoven, the Netherlands Frans Kampers in 1989 joined the Dutch agricultural research organization (DLO), which is now part of Wageningen University and Research Centre. He headed a department on instrumentation and measurement technology for several years. This department was involved in research on sensors, microelectronics and microtechnology. Among other things he was chairman of an ISO working group that defined the international standard on RFID for animals, chaired a working group on Microsystems and Agriculture and was responsible for a project on sensors for sustainable food production within the DTO programme.
Ritu Nalubola, Ph.D.
Ritu Nalubola, Ph.D. is a Senior Policy Advisor in FDA's Office of Policy, Office of the Commissioner. She advises senior leadership at FDA on complex and cross-cutting policy issues, including nanotechnology, genetic engineering, food safety, and nutrition. Her areas of expertise include emerging technologies, novel science-policy issues, food regulation and policy, and international consensus-based standards. In her current role, she leads the development and coordination of the Agency's regulatory policy activities relevant to the application of nanotechnology in FDA-regulated products. Dr. Nalubola also represents FDA in nanotechnology dialogue at various domestic and international policy forums. Prior to joining the Office of the Commissioner, Dr. Nalubola worked at FDA's Center for Food Safety and Applied Nutrition on a diverse range of food policy issues related to nutrition, labeling, food safety, and CODEX guidelines. She also worked with the U.S. Agency for International Development on international public health issues before starting her career at FDA in 2000.
Stephen Roberts, Ph.D.
Steve Roberts is Director of the Center for Environmental & Human Toxicology at the University of Florida, and is a Professor with joint appointments in the College of Veterinary Medicine, College of Medicine, and the College of Public Health and Health Professions. He received his Ph.D. in pharmacology from the University of Utah College of Medicine and subsequently completed an NIH postdoctoral fellowship in pharmacokinetics at SUNY Buffalo. He previously served as Chair of the Nanotechnology Working Group of the National Toxicology Program and is an Associate Editor of the journal Nanotoxicology. His research interests include methods for evaluating the safety of nanomaterials in vivo. His studies include the behavior of nanomaterials in the gastrointestinal tract and factors influencing their uptake after ingestion.
Lacey Simon is a native of Lafayette, Louisiana currently pursuing her master's degree in Biological Engineering at Louisiana State University, Baton Rouge. She received her BS in Biological Engineering in December of 2012 at LSU and immediately entered the master's program. Lacey has been involved with research involving nano-entrapment of bioactives including omega-3 and alpha-tocopherol. The current focus of Lacey's research is on bioavailability of alpha-tocopherol entrapped in polymeric nanoparticles. She published two papers, one entitled "Time analysis of poly(lactic-co-glycolic) acid nanoparticle uptake by major organs following acute intravenous and oral administration in mice and rats" featured in February 2013 edition of Industrial Biotechnology and one entitled "The effect of nanoparticle properties, detection method, delivery route, and animal model on poly(lactic-co-glycolic) acid nanoparticles biodistribution" in press in Drug Delivery Reviews.
Dr. Rajender (Raj) S. Varma
Dr. Raj Varma, obtained his Ph.D. from Delhi University in 1976. After postdoctoral positions at Robert Robinson Laboratories, University of Liverpool, UK, he was a faculty member at Baylor College of Medicine, Senior Scientist at Houston Advanced Research Center, and Research Professor at Sam Houston State University prior to joining as senior scientist in the Sustainable Technology Division at US Environmental Protection Agency in 1999. He has over 40 years of research experience in management of multi-disciplinary technical programs ranging from natural products chemistry and nanomaterials, to development of environmentally benign synthetic methods using microwaves, ultrasound and mechanochemical mixing. His long term goals are to contribute broad expertise in chemistry to evaluate novel and safer environmental protocols and its impact in human health and environmental sciences. He is on advisory board of several international journals and has been awarded 12 US Patents, published ~360 peer-reviewed papers, books, book chapters & encyclopedia contributions.
Dr. Rickey Yada
Dr. Rickey Yada received his Ph.D. from the Department of Food Science at the University of British Columbia in 1984. He has served as Chair of the Department of Food Science and as the Assistant Vice President Research, both at the University of Guelph. He is presently a Professor in the Department of Food Science, a Canada Research Chair in Food Protein Structure and the Scientific Director of the Advanced Foods and Materials Network in Canada. He has participated on numerous research awards panels and committees, both at the national and international levels. Among other activities, he is the Past Chair of the Scientific Council and President-Elect of the International Union of Food Science and Technology (IUFoST), is the North American Editor for Trends in Food Science and Technology and is on the editorial boards for several journals.